David received his B.Sc. in Life Sciences at the University of Toronto (Canada) and completed his Ph.D. in Pharmacology at the University of British Columbia (Canada) in 2023.
His research interests include psychopharmacology (e.g., antipsychotics and substance use) using meta-analytic and real-world approaches. David also works as a co-editor of the Clinical Handbook of Psychotropic Drugs, 25th Edition (Hogrefe Publishing).
In 2024, he joined the EBMPP group at the Technical University of Munich as a postdoctoral researcher and is currently working on a joint network meta-analysis of sexual side effects of antipsychotics in schizophrenia using both randomized and non-randomized studies. For more information, please refer to the published protocol. The project is funded by the Federal Ministry of Education and Research (BMBF).